‘Ent Devices Market Worth Over $15 Billion In 2017’ Says Visiongain Report

23 August 2017
Pharma

Visiongain’s new report The Global ENT Devices Market Forecast 2017-2027 - Revenue Prospects by Type (Diagnostic, Surgical, Hearing Devices), by Product (including Endoscopes, Surgical Instruments, Stents, CO2 Lasers, Vent Tubes, Hearing Aids, Hearing Implants and more) and Geography indicates that the ENT Devices market will see over $15bn in revenue in 2017.

The lead analyst of the report said:

“The ENT devices market is expected to experience considerable growth over the forecast period. The main drivers for the growth include a rapidly ageing population, rising prevalence of ENT diseases (such as adenoiditis, airway stenosis, allergic rhinitis, chronic ear disease, chronic tonsillitis, complex airway diseases, and ear infections or ear tubes), technological advancements in ENT devices to enhanced applications, and increasing adoption of minimally invasive ENT procedures. As per WHO estimates, 15% of the adult population and 33% of the elderly population across the globe suffer from hearing disorders. In addition to this, around 31 million people are estimated to suffer from sinusitis.

Technological innovations and the use of user-friendly materials in product development are set to drive the growth of this industry. A major contributor to growth is expected to be the use of thermoplastic materials for the development of custom external nasal splints, which will penetrate the market in next five years.”

The 146-page report contains 129 tables, charts and graphs that add visual analysis in order to explain developing trends within the ENT Devices. Visiongain provides revenue forecasts for the period 2017-2027 for the leading ENT Device submarkets, segmented by technology, with forecasts for Diagnostic ENT Devices, Surgical ENT Devices and Hearing Devices. The market is also segmented by product, and includes forecasts for ENT Endoscopes, including forecasts for Rigid and Flexible endoscopes and hearing screening devices in the diagnostic ENT device submarket. Also included are forecasts for Powered Surgical Instruments, Radiofrequency Handpieces, Handheld instruments, Balloon Sinus Dilation Systems, Nasal Splints & Stents, Bronchial/Tracheal Stents, Vent Tubes, CO2 Lasers and Image-guided surgery systems making up the Surgical ENT device submarket. Also included are forecasts for Hearing aids, including Behind-the-Ear (BTE) aids, In-the-ear aids, RITE aids and Canal hearing aids. Hearing implants, Cochlear Implants, Bone-Anchored Hearing Systems (BAHS) Auditory Brainstem Implants and Middle Ear Implants making up the Hearing device submarket.

The 146-page report offers market forecasts and analysis for 12 national markets. In addition, the report contains a dedicated leading companies’ chapter covering 5 companies leading the field in ENT Device technology in detail.

The Global ENT Devices Market Forecast 2017-2027 - Revenue Prospects by Type (Diagnostic, Surgical, Hearing Devices), by Product (including Endoscopes, Surgical Instruments, Stents, CO2 Lasers, Vent Tubes, Hearing Aids, Hearing Implants and more) and Geography report will be of value to anyone who wants to better understand the ENT Device market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the mass spectrometry industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

Read

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

Read

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

Read

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever